Crossmark

Anti-thyroglobulin antibodies do not significantly increase the risk of finding iodine avid metastases on post-radioactive iodine ablation scan in low-risk thyroid cancer patients

Crossref DOI link: https://doi.org/10.1007/s40618-017-0685-z

Published Online: 2017-05-16

Published Print: 2017-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nabhan, F.

Porter, K.

Senter, L.

Ringel, M. D.
Funding

Funding for this research was provided by:

National Institutes of Health (P01 CA124570 and P50CA168505)
License Information

Text and Data Mining valid from 2017-05-16

Version of Record valid from 2017-05-16
More Information

Article History

Received: 20 February 2017

Accepted: 3 May 2017

First Online: 16 May 2017

Compliance with ethical standards

:

: The authors have no conflict of interest.

: This study was approved by the Ohio State University Institutional Review Board.

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below